Solid Script
Investing in the exploration, design and optimization of DNA and RNA sequences to unlock new biological functions and their economic potential.
Solid Script is a venture platform built around a focused investment thesis: biological sequences are becoming increasingly designable assets.
We support selected seed-stage biotech projects exploring DNA and RNA sequences as tools to regulate cellular expression and generate new biological functions, helping promising research progress toward validation, IPR protection and commercial value.
Our focus lies at the convergence of sequence biology and artificial intelligence. As biological sequences become increasingly readable as a language, advances in AI and LLM are opening new possibilities for their exploration, design and optimization.
From sequence to function - From function to value.
Solid Script is currently supporting the discovery and validation of proprietary siRNA sequences designed to modulate inflammatory pathways involved in ocular Graft-versus-Host Disease (oGVHD). The project explores sequence-specific silencing as the foundation for new topically delivered RNA therapeutics.
Turning sequences into valuable biological assets requires measuring their effects in relevant biological environments. Solid Script is actively involved in the development of proprietary 3D cell and bioink printing solutions designed to reproduce tissue architecture and enable functional validation of sequence-driven interventions.
Solid Script explores innovative language-model approaches to biological sequence design. By treating DNA, RNA and proteins as information-rich languages, the project investigates how generative AI models can navigate sequence space and propose new sequences optimized for predefined biological functions.
Solid Script turns the knowledge and experience gained through its work on biological sequences into educational assets, translating cutting-edge research, technological development and real-world project experience into advanced training programs for scientific and professional audiences.
Solid Script - Via Fratelli Antegnati 12, 25065 Lumezzane BS (IT) - info@solidscript.it